A candid case study of a failed pharma startup deal — lessons on risk, relationships, and protecting a startup’s business.
A candid case study of a failed pharma startup deal — lessons on risk, relationships, and protecting a startup’s business.
Learn about the challenges of rare disease drug development and care and how digital health has the potential to revolutionize nearly every aspect.
A gap exists between pharma and digital health startup that prevents them from engaging in fruitful partnerships. What's going wrong?
To advance digital health, pharmaceutical companies and start-ups should partner. There are many benefits to both from working together.
What will 2020 and beyond bring for the digital health ecosystem?